The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose chemotherapy with methotrexate and vinblastine for Japanese patients with desmoid tumors: Relationship to CTNNB1 mutational status.
 
Yoshihiro Nishida
Consulting or Advisory Role - Seikagaku
Research Funding - Kyocera; Pfizer
Travel, Accommodations, Expenses - Chugai Pharma; Daiichi Sankyo; Lilly; Stryker
 
Satoshi Tsukushi
No Relationships to Disclose
 
Hiroshi Urakawa
No Relationships to Disclose
 
Shunsuke Hamada
No Relationships to Disclose
 
Eiji Kozawa
No Relationships to Disclose
 
Kunihiro Ikuta
No Relationships to Disclose
 
Yuichi Ando
Honoraria - ARKRAY; Bayer; Benesse Style Care; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen; Kowa; Kyowa Hakko Kirin; Lilly; Meiji Seika Kaisha; Merck; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; GlaxoSmithKline; Kowa; Novartis; Ono Pharmaceutical; Parexel
Research Funding - Chugai Pharma; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Merck Serono; Mitsubishi Tanabe Pharma; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Torii Pharmaceutical; Yakult Honsha
 
Naoki Ishiguro
Consulting or Advisory Role - Astellas Pharma; Eisai; Takeda
Research Funding - Daiichi Sankyo; Eisai; Mitsubishi Tanabe Pharma
Travel, Accommodations, Expenses - Novartis; Otsuka